English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Press release submission | May 13, 2022

Glycostem announces new data presentation at EHA 2022 Congress highlighting early safety and clinical course of oNKord® in patients with Acute Myeloid Leukemia

Press release submission | May 13, 2022

Studies Debunk COVID-19 Fertility & Transplant Concerns; Long-term Impact of COVID Yet to be Realized in Prostate & Bladder Cancer Patients

Press release submission | May 13, 2022

Baili Announces Clinical Trial Collaboration to Evaluate SI-B001, an EGFR x HER3 bispecific Antibody, in Combination with Tagrisso® in Patients with Non-Small Cell Lung Cancer

Press release submission | May 13, 2022

Idorsia U.S. Announces First Wave of Patients Prescribed QUVIVIQ (daridorexant) through Partnership with Pharmacy Services Provider

Press release submission | May 9, 2022

Mdgroup launches new enterprise solution Primarius3 to integrate how sites, sponsors, healthcare practitioners and patients connect at every stage of the clinical trial journey

Press release submission | Apr 28, 2022

Leading Physician and Telehealth Pioneer Advises that Patients With Pulmonary Disorders Can Benefit From Remote Patient Monitoring Devices

Press release submission | Apr 21, 2022

Zambon Receives U.S. FDA Breakthrough Therapy Designation for CMS I-neb® in Patients with Non-Cystic Fibrosis Bronchiectasis (NCFB)

Press release submission | Apr 18, 2022

Alabama Patients Have Increased Access to Affordable, Quality Anesthesia Care

Trending

Patient Daily | Oct 23, 2025

Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues

Patient Daily | Oct 23, 2025

Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'

+ Pharmaceuticals
Patient Daily | Oct 23, 2025

Empower seeks dismissal of Eli Lilly suit in Texas federal court

+ Pharmaceuticals
Patient Daily | Oct 29, 2025

Paragon Health Institute senior fellow: 340B program 'needs real reform'

  • « First
  • «
  • …
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily